Crinetics Pharmaceuticals, Inc.
CRNX
12 insider filings · Latest: Apr 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Jan 2 9:31 PM | DANA PIZZUTI | Proposed Sale | 5,000 | $46.55 | $232.8K | — | View → |
| Dec 1, 2025 | Dec 1 9:37 PM | DANA PIZZUTI | Proposed Sale | 5,000 | $45.56 | $227.8K | — | View → |
| Nov 3, 2025 | Nov 3 9:26 PM | DANA PIZZUTI | Proposed Sale | 5,000 | $43.50 | $217.5K | — | View → |
| Oct 1, 2025 | Oct 1 8:30 PM | DANA PIZZUTI | Proposed Sale | 5,000 | $41.65 | $208.3K | — | View → |
| Sep 26, 2025 | Sep 26 8:27 PM | MATTHEW K FUST | Proposed Sale | 16,000 | $35.89 | $574.2K | — | View → |
| Sep 26, 2025 | Sep 26 8:09 PM | Struthers Richard Scott | Proposed Sale | 4,000 | $45.00 | $180.0K | — | View → |
| Sep 2, 2025 | Sep 2 8:41 PM | DANA PIZZUTI | Proposed Sale | 5,000 | $30.99 | $154.9K | — | View → |
| Aug 22, 2025 | Aug 22 8:44 PM | DANA PIZZUTI | Proposed Sale | 30,000 | $29.40 | $882.0K | — | View → |
| Aug 20, 2025 | Aug 20 8:24 PM | DANA PIZZUTI | Proposed Sale | 6,492 | $29.43 | $191.1K | — | View → |
| Jun 12, 2025 | Jun 12 8:19 PM | STEPHEN BETZ | Proposed Sale | 97,483 | $32.33 | $3.2M | — | View → |
| Feb 3, 2025 | Feb 3 9:11 PM | DANA J PIZZUTI | Proposed Sale | 5,000 | $39.07 | $195.4K | — | View → |
| Jan 3, 2025 | Jan 3 9:12 PM | DANA J PIZZUTI | Proposed Sale | 15,000 | $52.09 | $781.3K | — | View → |
| Dec 2, 2024 | Dec 2 9:06 PM | Struthers Richard Scott | Proposed Sale | 10,000 | $57.27 | $572.7K | — | View → |
| Oct 3, 2024 | Oct 3 8:08 PM | DANA J PIZZUTI | Proposed Sale | 14,375 | $54.63 | $785.3K | — | View → |
| Sep 26, 2024 | Sep 26 8:06 PM | MARC WILSON | Proposed Sale | 25,000 | $51.11 | $1.3M | — | View → |
| Sep 10, 2024 | Sep 10 4:11 PM | Betz Stephen F. | Proposed Sale | 1,035 | $51.50 | $53.3K | — | View → |
| Aug 26, 2024 | Aug 26 5:16 PM | Betz Stephen F. | Proposed Sale | 3,000 | $53.19 | $159.6K | — | View → |
← Previous
Page 2 of 2
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 8, 2026 | Apr 10 8:33 PM | Jeff E. KnightChief Dev. & Operating Officer | Option Exercise | 78,434 | $23.98 | 65,977(D) | View → |
| Feb 23, 2026 | Feb 25 9:37 PM | Struthers Richard ScottDirector, President & CEO | Grant/Award | 228,000 | $43.79 | 228,000(D) | View → |
| Feb 23, 2026 | Feb 25 9:36 PM | Tobin SchilkeChief Financial Officer | Grant/Award | 50,000 | $43.79 | 50,000(D) | View → |
| Feb 23, 2026 | Feb 25 9:34 PM | Jeff E. KnightChief Operating Officer | Grant/Award | 55,000 | $43.79 | 55,000(D) | View → |
| Feb 23, 2026 | Feb 25 9:34 PM | Stephen F. BetzChief Scientific Officer | Grant/Award | 47,000 | $43.79 | 47,000(D) | View → |
| Feb 23, 2026 | Feb 25 9:32 PM | Isabel KalofonosChief Commercial Officer | Grant/Award | 55,000 | $43.79 | 55,000(D) | View → |